glp 1 agonist prescription GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness How GLP-1 medications are transforming

A third, recent study in JAMA Network Open , from August of 2025, analyzed data from 159,000 people with type 2 diabetes who took semaglutide or tirzepatide (Mounjaro, Zepbound)

Journal reference: Corrao S, Pollicino C, Maggio D, Torres A and Argano C (2024) Tirzepatide against obesity and insulin-resistance: pathophysiological aspects and clinical evidence

For instance, in April 2026, according to data published by Lancet under the journal of public health in Germany, Germany's public health system faces challenges despite high spending, with rising rates of lifestyle-related diseases like obesity, smoking, and heart disease

Nutr Rev

Qi, C., Mao, X., Zhang, Z

Eng approached Raufman after his talk and suggested they team up to search Gila monster venom for additional peptides with structures similar to the exendin-1 and exendin-2 molecules that Raufman first discovered